OncoCyte Corp (NAS:OCX)
$ 2.81 0.05 (1.81%) Market Cap: 37.55 Mil Enterprise Value: 34.51 Mil PE Ratio: 0 PB Ratio: 2.01 GF Score: 34/100

Q1 2024 OncoCyte Corp Earnings Call Transcript

May 15, 2024 / 08:30PM GMT
Release Date Price: $2.95 (+1.72%)

Good afternoon. My name is Brianna, and I will be your conference operator today. At this time, I would like to welcome everyone to the OncoCyte first-quarter 2024 earnings conference call. Please note that this call is being recorded. (Operator Instructions)

I will now turn today's call over to Jeff Hanson, CEO of PCG Advisory. Please go ahead.

Jeff Ramson
PCG Advisory Group - Chief Executive Officer

Thank you, Brianna, and thank you to everyone for joining us for today's conference call to discuss OncoCyte first-quarter 2024 financial results and recent operating highlights. If you've not seen today's financial results press release, please visit the company's website on the Investors page.

Before turning the call over to Josh Riggs, OncoCyte√Ęs President and CEO, I√Ęd like to remind you that during this conference call, the company will make projections, and forward-looking statements regarding future events.

Any statements that are not historical facts are forward-looking statements. We encourage you to review the company√Ęs SEC

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot